Bronwyn M Gunn (Bronwyn Gunn)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Monoclonal Antibody

Respiratory Syndrome Coronavirus

Top Venues

Communications biology

Research square

Science translational medicine

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Bukreyev, Michelle Meyer, Bronwyn M Gunn, Colette A Pietzsch, Chandru Subramani, Erica Ollmann Saphire, James E Crowe, Galit Alter, Sunny Himansu, Andrea Carfi
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Research square (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Alexander Bukreyev, Michelle Meyer, Bronwyn M Gunn, Colette A Pietzsch, Chandru Subramani, Erica Ollmann Saphire, James E Crowe, Galit Alter, Sunny Himansu, Andrea Carfi
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Research square (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Alexander Bukreyev, Michelle Meyer, Bronwyn M Gunn, Colette A Pietzsch, Chandru Subramani, Erica Ollmann Saphire, James E Crowe, Galit Alter, Sunny Himansu, Andrea Carfi
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Research square (2024)
Alexander Bukreyev, Michelle Meyer, Bronwyn M Gunn, Colette A Pietzsch, Chandru Subramani, Erica Ollmann Saphire, James E Crowe, Galit Alter, Sunny Himansu, Andrea Carfi
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Research square (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement. Communications biology 7 (1) (2024)
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A Hyde, Jalene V Velazquez, Lauren E Williamson, Pavlo Gilchuk, Robert H Carnahan, Galit Alter, James E Crowe, Alexander Bukreyev
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system. Communications biology 7 (1) (2024)
Alexander Bukreyev, Philipp Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Pavlo Gilchuk, Galit Alter, James E Crowe
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research square (2023)
Alexander Bukreyev, Philipp Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Pavlo Gilchuk, Galit Alter, James E Crowe
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research square (2023)
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
Alexander Bukreyev, Philipp Ilinykh, Kai Huang, Bronwyn M Gunn, Natalia A Kuzmina, Pavlo Gilchuk, Galit Alter, James E Crowe
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research square (2023)
Michelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, Karthik Gangavarapu, Asuka Yoshida, Colette A Pietzsch, Natalia A Kuzmina, Erica Ollmann Saphire, Peter Leon Collins, James E Crowe, James J Zhu, Marc A Suchard, Douglas L Brining, Chad E Mire, Robert W Cross, Joan B Geisbert, Siba K Samal, Kristian G Andersen, Galit Alter, Thomas W Geisbert, Alexander Bukreyev
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects. Science translational medicine 13 (602) (2021)
Maria Tokuyama, Bronwyn M Gunn, Arvind Venkataraman, Yong Kong, Insoo Kang, Tasfia Rakib, Michael J Townsend, Karen H Costenbader, Galit Alter, Akiko Iwasak
Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. The Journal of experimental medicine 218 (7) (2021)
Bronwyn M Gunn, Shuangyi Bai
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection. Human vaccines & immunotherapeutics (2021)
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M Deveau, Thomas J Yockachonis, Andrew S Herbert, Michael B Battles, Cecilia M O'Brien, Michael E Brown, James C Geoghegan, Jonathan Belk, Linghang Peng, Linlin Yang, Yixuan J Hou, Trevor D Scobey, Dennis R Burton, David Nemazee, John M Dye, James E Voss, Bronwyn M Gunn, Jason S Mclellan, Ralph S Baric, Lisa E Gralinski, Laura M Walker
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science (New York, N.Y.) 371 (6531) (2021)
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M Deveau, Thomas J Yockachonis, Andrew S Herbert, Michael B Battles, Cecilia M O'Brien, Michael E Brown, James C Geoghegan, Jonathan Belk, Linghang Peng, Linlin Yang, Trevor D Scobey, Dennis R Burton, David Nemazee, John M Dye, James E Voss, Bronwyn M Gunn, Jason S Mclellan, Ralph S Baric, Lisa E Gralinski, Laura M Walker
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. bioRxiv : the preprint server for biology (2020)
Julie M Fox, Vicky Roy, Bronwyn M Gunn, Ling Huang, Melissa Anne Edeling, Matthias Mack, Daved H Fremont, Benjamin J Doranz, Syd Johnson, Galit Alter, Michael S. Diamond
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science immunology 4 (32) (2020)